olak, E., Kozi, D., Jovi, J., Risti, G., & Kovaevi, L
Some healthcare providers may consider combining GLP-1 receptor agonists with SGLT2 inhibitors, given their distinct mechanisms of action
Safety Concerns and Liability Issues Like all pharmaceuticals, GLP-1 medications carry inherent safety challenges, including the risk of unanticipated adverse side effects
How semaglutide works Semaglutide works for weight loss and diabetes the following ways: Targets GLP-1 receptors to reduce the feeling of hunger Slows down stomach emptying to give you a feeling of fullness for a longer time Reduces craving for fatty foods and binge eating Increases the levels of free leptin and decreases ghrelin levels to promote weight loss Similarities Semaglutide and liraglutide belong to the same class of medication (GLP-1 agonists) and share a few similarities: Mechanism of action Both medications belong to a class of GLP-1 receptor agonists